EnginZyme, a Stockholm, Sweden-based green tech company, raised €21M in Series B funding.
The investors included Almi Invest GreenTech, Navigare Ventures, Bunge Ventures, Sofinnova Partners, Industrifonden and SEB GreenTech VC.
The company intends to use the funds to execute its plans for large-scale commercialization and build new features of its proprietary technology platform to enhance performance and facilitate scaling in current and new markets.
Led by CEO Karim Engelmark Cassimjee, EnginZyme develops biomanufacturing processes for the sustainable manufacturing of everyday products. Its technology platform uses nature’s catalysts, enzymes, combining biology with chemical industry in a single solution.
FinSMEs
19/12/2022